The Determinants of Delays and Their Impact on Clinical End Points in Acute ST-Segment Elevation Myocardial
Kardelen Ohtaroglu Tokdil1, Hasan Tokdil2, Eser Durmaz1
1Division of Cardiology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, 34098 Istanbul, Turkey.
Insights
Factors like BMI, diabetes, and hypertension significantly delay treatment for ST-elevation myocardial infarction (STEMI) patients. Early intervention improves prognosis, reducing cardiac events and mortality.
Area of Science:
- Cardiology
- Public Health
Background:
- ST-elevation myocardial infarction (STEMI) is a critical condition requiring rapid treatment.
- Delays in treatment negatively impact patient prognosis and outcomes.
Purpose of the Study:
- To identify factors contributing to treatment delay in STEMI patients.
- To investigate the impact of treatment delay on major adverse cardiac events.
Main Methods:
- A study of 301 STEMI patients undergoing primary percutaneous coronary intervention (pPCI).
- Analysis of patient demographics, clinical factors, and treatment times.
- Assessment of major cardiac clinical events and follow-up data.
Main Results:
- Obesity (BMI), diabetes, hypertension, smoking, and pain intensity variability were linked to longer delays.
- Independent predictors of delay included BMI, diabetes, hypertension, smoking, pain intensity, and non-LAD infarct artery.
- Early presentation correlated with lower NT-proBNP and improved ejection fraction.
Conclusions:
- Prolonged ischemia in STEMI is influenced by patient and system factors.
- Timely reperfusion is crucial for reducing mortality and clinical events in STEMI.
- Enhancing patient education, emergency response, and hospital protocols can minimize delays and improve STEMI outcomes.
Abstract:
Background and Objectives: The purpose of this study was to determine the factors that cause delay time in patients admitted to the hospital with STEMI. In addition, the effect of this delay on the patient's prognosis has also been investigated. Materials and Methods: a total of 301 patients diagnosed with STEMI treated with primary percutaneous coronary intervention (pPCI) were included in the study. Reinfarction, revascularization, cerebrovascular event, and cardiac death were determined as major cardiac clinical events. The follow-up period of our study was 475 ± 193 days. Results: Univariate analysis revealed that factors influencing delay time included BMI, hypertension diabetes, smoking habit and variability in pain intensity. In multivariate logistic regression analysis, BMI, diabetes, hypertension, smoking, variation in pain intensity, and infarct-related artery other than the LAD were identified as independent factors associated with increased delay times. We determined the cut-off values predicting the composite endpoint as 122.5 min for patient delay, 95.5 min for system delay, and 371 min for total ischemic time. It was observed that the in-hospital NT pro-BNP values of the patients presenting early were lower (181 vs. 594 pg/mL p < 0.001), had a higher ejection fraction at the first measurement, and even improved at the sixth week of follow-up (p = 0.047). Conclusions: Prolonged ischemia duration was associated with several factors. Early reperfusion in STEMI patients reduces both cardiac death and clinical events. Delays are influenced by patient awareness, emergency care efficiency, and hospital-specific factors. Improving education, response times, and hospital protocols is essential to minimize delays and improve outcomes.
More Related Videos
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
09:21Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
